StonvexLoading…
StonvexStonvexStonvexCore line items from PBYI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $54.06M | $44.81M | $228.37M | $152.92M | $98.44M |
Operating Income | Not available | $-3.83M | $37.30M | $20.19M | $10.62M |
Net Income | Not available | $-3.75M | $31.11M | $17.67M | $8.83M |
EPS (Diluted) | $0.04 | $-0.07 | $0.61 | $0.35 | $0.18 |
Total Assets | Not available | $192.70M | $216.30M | $202.86M | $194.92M |
Total Liabilities | Not available | $64.28M | $85.96M | $87.59M | $90.20M |
Cash & Equivalents | Not available | $36.19M | $29.64M | $53.52M | $54.66M |
Free Cash Flow OCF − CapEx | Not available | $15.42M | $41.73M | $27.28M | $17.61M |
Shares Outstanding | Not available | 50.88M | 50.41M | 50.38M | 49.89M |